MADISON, Wis.--(BUSINESS WIRE)--Drug developers have a new bioluminescent tool to characterize how potential pharmaceuticals behave in biologically relevant systems. A new primary cell bioassay from ...
OrganaBio, announced the opening of a new PBMC processing and cryopreservation laboratory at Excellos Labs in San Diego, further strengthening its nationwide network supporting cell therapy developers ...
OrganaBio, LLC ("OrganaBio"), a manufacturer of Research- and cGMP-grade cells and blood-derived products and provider of cell isolation and cryopreservation services, today announced the opening of a ...
SAN FRANCISCO--(BUSINESS WIRE)--OrganaBio, LLC, a leading provider of human research- and clinical-grade cellular starting materials and clinical trial support services today announced the opening of ...
Standardization and reproducibility are prerequisites for peripheral blood mononuclear cell (PBMC) generation from donor or patient samples in PBMC-based studies. Whether you are analyzing ...
Fast, local cryopreservation is a consistent bottleneck for autologous cell therapy developers, even in major cell and gene therapy hubs. For the peripheral blood mononuclear cells (PBMCs) that form ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results